Submuscular Breast Augmentation

Breast augmentation is a procedure in which implants are inserted into the breasts to increase their size, change their shape, or make them more even. A key decision made with the surgeon at the consultation is where the implant sits: either behind the breast tissue (in front of the chest muscle) or behind the chest muscle. Positioning the implant behind the chest muscle is what is meant by submuscular placement. Implants are usually filled with silicone gel or salt water (saline). Beyond cosmetic enlargement, breast implants are also used to reconstruct the breast after cancer surgery or injury and to correct developmental differences such as marked asymmetry. Recovery typically involves taking a week or two off work, not driving for at least a week, and avoiding heavy lifting or strenuous exercise for at least a month, with a supportive bra recommended by some surgeons for a time. Recognised risks include capsular contracture, implant rupture or rotation, rippling, changes in nipple sensation, and, rarely, a cancer of the immune system associated with breast implants (BIA-ALCL). The implant type and where it is placed should be discussed fully with the surgeon.

*Overview adapted from NHS (breast enlargement) under the Open Government Licence v3.0, and from Wikipedia (Breast augmentation) under CC BY-SA 4.0. Verify with a qualified clinician before treatment.*

Submuscular breast augmentation is typically priced at the same level as subglandular at most clinics; both involve identical implant cost and similar operative time. Total cost depends on implant brand and type (cohesive silicone vs saline, smooth vs textured), surgeon's fee, anaesthetic fee, and facility fee. Quoted prices usually include the implant, the procedure, anaesthesia, and a short period of follow-up. Implant warranties (lifetime against rupture, 10-year against capsular contracture) are usually included by the manufacturer.

Days 0-3: most painful phase. Chest tightness, muscle spasm, and difficulty lifting arms above shoulder height. Sleep upright or in a recliner. Prescribed analgesia and muscle relaxants are usually required. Light walking is encouraged from day 1.

Days 4-7: pain decreases substantially. Most patients can lift arms to head height by day 5-7. Showering permitted once dressings are removed (typically day 2-3). No driving while taking opioid analgesia.

Week 2: return to sedentary work for most patients. Continued use of supportive surgical bra. Wound review at 1-2 weeks. No upper-body exercise; no lifting more than 2-3kg.

Week 4-6: gradual return to upper-body exercise. Implants begin to 'drop and fluff' into final position over weeks 4-12. Continued surgical bra during the day; sports bra at night for upper-pole support.

Month 3: most patients reach near-final result and full unrestricted activity. Final implant position and shape continue refining for up to 12 months.

Month 6-12: long-term surveillance begins. Annual review with the surgeon is recommended for the first 2 years, then biennial. Implant-specific MRI surveillance for silicone implants is recommended in some jurisdictions (FDA in the US recommends from 5 years).

Submuscular breast augmentation requires the same in-country stay as subglandular augmentation (7-10 days) but pain in the first week is more pronounced because the pectoralis major muscle is stretched. International patients should plan for 5-7 days locally before flying long-haul; DVT prophylaxis is recommended after general anaesthesia.

The implant brand, model, size, lot number, and surface texture must be documented in the implant passport for lifetime surveillance — this is non-negotiable for any breast augmentation regardless of pocket placement. The implant passport will be needed for any subsequent imaging, recall response, or revision surgery.